2 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... thrombosis; PE = pulmonary ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation ... Imaging: CXR- pulmonary ... #Syndrome #APML ... #diagnosis #management ... #hematology #oncology